Major study supports off-pump heart bypass surgery
This article was originally published in Clinica
Executive Summary
Evidence is mounting to support beating-heart - or off-pump - bypass surgery, after early results from a major clinical trial indicated that technique is as safe and effective as standard coronary bypass surgeries.
You may also be interested in...
‘Potential Misconduct’ Shuts EuroAPI Plant In Italy As 2024 Guidance Suspended
EuroAPI is on the backfoot once again after being forced to suspend production at its manufacturing site in Brindisi, Italy, weeks after unveiling a four-year strategic roadmap that sought to tighten and focus its operations amid a challenging two years.
‘Parity To The Originator Is Not Enough’ – Cardinal Health Talks US Biosimilars
Following what Cardinal Health described as “a year of monumental developments in biosimilars,” the firm’s director of biosimilars, Dracey Poore, spoke to Generics Bulletin for an exclusive Q&A.
Fresenius And Formycon Strike Stelara Settlement For Europe And Canada
Partners Fresenius Kabi and Formycon have laid the groundwork to launch their biosimilar ustekinumab rival to Stelara in Europe and Canada through a settlement agreement with originator J&J.